Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine dose comparison combined with sufentanil for postoperative intravenous analgesia
ChiCTR-IPD-16009745Phase 4Not yet recruiting
- Sponsor
- Liaocheng City People's Hospital
- Start
- Dec 2016
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of dexmedetomidine and sufentanil in acute pain (4 arms), sponsored by Liaocheng City People's Hospital. Primary endpoints: Pain score and Analgesic drug consumption. Planned start Dec 2016; status: not yet recruiting.
02
Drugs
dexmedetomidinesufentanil
03
Conditions
acute pain
Beyond the preview
Go deeper on ChiCTR-IPD-16009745.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPD-16009745.